A key component of BioNTech’s commercial strategy is to collaborate with partners that have a similar fascination, drive and commitment in developing and commercializing truly innovative and disruptive immunotherapies.
As a fully integrated biopharmaceutical company with cutting edge technologies BioNTech AG is actively engaged in many collaborations, partnerships and licensing deals supporting development of first in class therapies.
BioNTech AG also benefits from a global network of academic partners, which we leverage for leading clinical opinion, scientific expertise and novel ideas, the latter of which we translate in collaboration with our partners into successful commercial products.
Our current partnerships are a testament to our ability to execute.
BioNTech has pharma collaborations in each of our therapeutic businesses:
To learn more about partnering, licensing, collaborations, partnerships, or for any scientific inquiries, please contact:
An der Goldgrube 12